[Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D004837:Epinephrine; D006168:Guinea Pigs; D008026:Ligation; D010042:Ouabain; D011412:Propanolamines; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D012584:Sciatic Nerve / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology / Q000627:therapeutic use; D013876:Thiophenes
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D001578:Benzopyrans; D011412:Propanolamines; D011437:Propylamines; D013440:Sulfides; D013876:Thiophenes; D010042:Ouabain; D011433:Propranolol; C005632:tertatolol; D004837:Epinephrine
Etude des effets anti-arythmisants d'un adrénolytique bêta, le dl (hydroxy 2't-butylamino-3' porpyloxy) 8-thiochromane (S 2395.